Cancers are marked by an elevated rate of cell replication; this is often a result of an abnormal presentation of particular cell signaling pathways. Some treatments for cancer modulate these overactive pathways by targeting certain pathway essential proteins, through inhibition of function, post-transcription modifications, gene therapy and epigenetic modulation.
Related Illustrations
